Name Funds
holding
Growth Growth % Return since
31 Dec ‘18
1376
4 -2 -33% 124%
1377
6 -3 -33% 93.9%
1378
6 -3 -33% 67.4%
BIB icon
1379
ProShares Ultra NASDAQ Biotechnology
BIB
$66.7M
27 -14 -34% 63.5%
1380
13 -7 -35% 99.9%
1381
24 -13 -35% 126%
1382
11 -6 -35% 95%
1383
9 -5 -36% 169%
1384
9 -5 -36% 24.2%
1385
9 -5 -36%
CANF
1386
Can-Fite BioPharma
CANF
$8.81M
7 -4 -36% 99.7%
1387
10 -6 -38% 19.6%
1388
3 -2 -40% 39.1%
1389
3 -2 -40% 79.5%
1390
6 -4 -40% 99.9%
1391
9 -6 -40% 96.5%
1392
10 -7 -41% 93.7%
1393
10 -7 -41% 91.4%
1394
11 -8 -42% 81.8%
1395
11 -8 -42% 96.3%
1396
4 -3 -43% 62%
1397
8 -6 -43% 95.9%
1398
12 -9 -43% 64.4%
1399
5 -4 -44% 175%
1400
14 -12 -46% 57.1%